Par Drugs and Chemicals Limited
NSE:PAR.NS
234.05 (INR) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 956.404 | 950.951 | 742.001 | 598.8 | 550.966 | 455.973 | 420.342 | 467.188 | 332.642 |
| Cost of Revenue
| 427.268 | 664.049 | 498.637 | 374.37 | 396.271 | 324.892 | 295.261 | 351.152 | 128.608 |
| Gross Profit
| 529.136 | 286.902 | 243.364 | 224.43 | 154.695 | 131.081 | 125.081 | 116.036 | 204.034 |
| Gross Profit Ratio
| 0.553 | 0.302 | 0.328 | 0.375 | 0.281 | 0.287 | 0.298 | 0.248 | 0.613 |
| Reseach & Development Expenses
| 1.081 | 1.006 | 0.147 | 0.988 | 0.666 | 0.543 | 0.225 | 0 | 0 |
| General & Administrative Expenses
| 0 | 12.41 | 14.552 | 7.907 | 12.613 | 9.86 | 4.415 | 4.633 | 0 |
| Selling & Marketing Expenses
| 0 | 47.638 | 32.572 | 21.679 | 11.838 | 8.14 | 6.883 | 10.516 | 0 |
| SG&A
| 335.323 | 60.048 | 47.124 | 29.587 | 24.452 | 18 | 11.298 | 15.149 | 22.085 |
| Other Expenses
| 2.423 | 2.383 | 1.839 | 0.508 | 66.858 | 63.305 | 65.43 | 45.114 | 0 |
| Operating Expenses
| 335.323 | 141.379 | 116.811 | 92.81 | 90.178 | 79.387 | 76.623 | 59.624 | 159.334 |
| Operating Income
| 193.813 | 149.742 | 129.735 | 131.935 | 66.872 | 51.694 | 48.458 | 56.412 | 45.381 |
| Operating Income Ratio
| 0.203 | 0.157 | 0.175 | 0.22 | 0.121 | 0.113 | 0.115 | 0.121 | 0.136 |
| Total Other Income Expenses Net
| 1.353 | 1.05 | -2.703 | 15.326 | -6.953 | -18.857 | -22.928 | -24.579 | -35.313 |
| Income Before Tax
| 195.166 | 150.792 | 127.032 | 147.261 | 59.919 | 32.837 | 25.53 | 31.833 | 10.068 |
| Income Before Tax Ratio
| 0.204 | 0.159 | 0.171 | 0.246 | 0.109 | 0.072 | 0.061 | 0.068 | 0.03 |
| Income Tax Expense
| 50.156 | 37.451 | 34.881 | 31.149 | 12.269 | 8.649 | 10.577 | 13.355 | 5.85 |
| Net Income
| 145.01 | 113.341 | 92.133 | 116.112 | 47.65 | 24.188 | 14.953 | 18.478 | 4.218 |
| Net Income Ratio
| 0.152 | 0.119 | 0.124 | 0.194 | 0.086 | 0.053 | 0.036 | 0.04 | 0.013 |
| EPS
| 11.78 | 9.21 | 7.49 | 18.87 | 7.75 | 1.97 | 1.22 | 1.5 | 0.78 |
| EPS Diluted
| 11.78 | 9.21 | 7.49 | 18.87 | 7.75 | 1.97 | 1.22 | 1.5 | 0.78 |
| EBITDA
| 228.174 | 181.484 | 163.622 | 161.559 | 94.7 | 81.322 | 76.8 | 84.368 | 71.877 |
| EBITDA Ratio
| 0.239 | 0.191 | 0.221 | 0.27 | 0.172 | 0.178 | 0.183 | 0.181 | 0.216 |